Altimmune Inc (ALT)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-03-18 | 2025-03-17 | B Purchase | Non-Executive Director |
1,000
+inf%
5.78USD 5,785 |
1,000 +inf% | 5.78 | USD 5,785 | |
| 2025-03-14 | 2025-03-13 | B Purchase |
Chief Financial Officer Officer |
10,000
+inf%
5.20USD 51,996 |
10,000 +inf% | 5.20 | USD 51,996 | |
| 2024-08-20 | 2024-08-19 | S Sale | Non-Executive Director |
8,184
-12.8%
6.88USD 56,306 |
8,184 -12.8% | 6.88 | USD 56,306 | |
| 2024-08-20 | 2024-08-19 | S Sale | Non-Executive Director |
7,827
-15.7%
6.93USD 54,241 |
7,827 -15.7% | 6.93 | USD 54,241 | |
| 2023-08-15 | 2023-08-15 | B Purchase | Non-Executive Director |
300
+1.0%
2.88USD 863 |
300 +1.0% | 2.88 | USD 863 | |
| 2023-03-24 | 2023-03-24 | B Purchase |
Chief Financial Officer Officer |
10,000
+83.3%
4.31USD 43,140 |
10,000 +83.3% | 4.31 | USD 43,140 | |
| 2023-03-27 | 2023-03-23 | B Purchase | Non-Executive Director |
9,000
+43.9%
4.27USD 38,430 |
9,000 +43.9% | 4.27 | USD 38,430 | |
| 2023-03-23 | 2023-03-23 | B Purchase |
Chief Medical Officer Officer |
10,000
+42.9%
4.22USD 42,200 |
10,000 +42.9% | 4.22 | USD 42,200 | |
| 2022-12-22 | 2022-12-22 | PS Planned sale | Non-Executive Director |
20,000
-70.2%
15.01USD 300,268 |
20,000 -70.2% | 15.01 | USD 300,268 | |
| 2022-09-01 | 2022-08-31 | PS Planned sale |
President and CEO Executive Director |
20,000
-7.8%
20.02USD 400,322 |
20,000 -7.8% | 20.02 | USD 400,322 | |
| 2023-07-06 | 2022-08-12 | S Sale | Non-Executive Director |
2,714
-49.5%
15.00USD 40,710 |
2,714 -49.5% | 15.00 | USD 40,710 | |
| 2022-08-12 | 2022-08-12 | PS Planned sale |
President and CEO Executive Director |
15,000
-5.5%
15.06USD 225,890 |
15,000 -5.5% | 15.06 | USD 225,890 | |
| 2022-07-05 | 2022-07-05 | PS Planned sale |
Chief Scientific Officer Officer |
10,182
-55.1%
12.00USD 122,184 |
10,182 -55.1% | 12.00 | USD 122,184 | |
| 2022-07-05 | 2022-07-01 | PS Planned sale |
Chief Scientific Officer Officer |
26,982
-60.4%
12.00USD 323,784 |
26,982 -60.4% | 12.00 | USD 323,784 | |
| 2022-06-28 | 2022-06-27 | PS Planned sale |
Chief Scientific Officer Officer |
37,352
-67.8%
12.00USD 448,254 |
37,352 -67.8% | 12.00 | USD 448,254 | |
| 2022-06-28 | 2022-06-27 | PS Planned sale | Non-Executive Director |
17,610
-100.0%
11.75USD 206,944 |
17,610 -100.0% | 11.75 | USD 206,944 | |
| 2022-06-16 | 2022-06-15 | B Purchase | Non-Executive Director |
1,000
+5.3%
8.00USD 8,000 |
1,000 +5.3% | 8.00 | USD 8,000 | |
| 2022-05-25 | 2022-05-24 | B Purchase | Non-Executive Director |
1,200
+6.7%
4.50USD 5,400 |
1,200 +6.7% | 4.50 | USD 5,400 | |
| 2022-03-02 | 2022-02-28 | PS Planned sale |
Chief Medical Officer Officer |
30,000
-72.2%
7.52USD 225,600 |
30,000 -72.2% | 7.52 | USD 225,600 | |
| 2021-03-01 | 2021-03-01 | PS Planned sale | Non-Executive Director |
6,000
-40.7%
16.08USD 96,480 |
6,000 -40.7% | 16.08 | USD 96,480 | |
| 2020-12-11 | 2020-12-10 | B Purchase | Non-Executive Director |
2,000
+29.0%
11.99USD 23,980 |
2,000 +29.0% | 11.99 | USD 23,980 | |
| 2020-12-02 | 2020-12-01 | PS Planned sale | Non-Executive Director |
1,227
-100.0%
13.54USD 16,614 |
1,227 -100.0% | 13.54 | USD 16,614 | |
| 2020-12-02 | 2020-11-30 | PS Planned sale | Non-Executive Director |
8,425
-42.9%
11.92USD 100,426 |
8,425 -42.9% | 11.92 | USD 100,426 | |
| 2020-12-02 | 2020-11-30 | PS Planned sale | Non-Executive Director |
2,500
-14.5%
12.00USD 30,000 |
2,500 -14.5% | 12.00 | USD 30,000 | |
| 2020-11-13 | 2020-11-12 | PS Planned sale | Non-Executive Director |
10,150
-59.5%
9.91USD 100,587 |
10,150 -59.5% | 9.91 | USD 100,587 | |
| 2020-11-13 | 2020-11-12 | PS Planned sale | Non-Executive Director |
10,352
-54.9%
9.90USD 102,485 |
10,352 -54.9% | 9.90 | USD 102,485 | |
| 2020-11-13 | 2020-11-12 | PS Planned sale | Non-Executive Director |
4,015
-49.7%
10.02USD 40,230 |
4,015 -49.7% | 10.02 | USD 40,230 | |
| 2020-06-15 | 2020-06-15 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
1,500,000
+50.0%
7.54USD 11,310,000 |
1,500,000 +50.0% | 7.54 | USD 11,310,000 | |
| 2020-05-28 | 2020-05-28 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
173,711
+6.1%
8.87USD 1,540,817 |
173,711 +6.1% | 8.87 | USD 1,540,817 | |
| 2020-05-28 | 2020-05-28 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
27,763
+1.0%
7.79USD 216,274 |
27,763 +1.0% | 7.79 | USD 216,274 | |
| 2020-05-28 | 2020-05-27 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
277,000
+11.0%
7.92USD 2,193,840 |
277,000 +11.0% | 7.92 | USD 2,193,840 | |
| 2020-05-28 | 2020-05-27 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
125,162
+5.2%
7.23USD 904,921 |
125,162 +5.2% | 7.23 | USD 904,921 | |
| 2020-05-28 | 2020-05-26 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
390,547
+19.5%
9.78USD 3,819,550 |
390,547 +19.5% | 9.78 | USD 3,819,550 | |
| 2020-05-28 | 2020-05-26 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
309,453
+18.2%
8.79USD 2,720,092 |
309,453 +18.2% | 8.79 | USD 2,720,092 | |
| 2020-05-18 | 2020-05-15 | S Sale |
VELOCITY PHARMACEUTICAL HOLDINGS LLC Large shareholder |
30,622
-1.8%
4.65USD 142,392 |
30,622 -1.8% | 4.65 | USD 142,392 | |
| 2020-05-18 | 2020-05-14 | S Sale |
VELOCITY PHARMACEUTICAL HOLDINGS LLC Large shareholder |
169,378
-9.0%
4.81USD 814,708 |
169,378 -9.0% | 4.81 | USD 814,708 | |
| 2019-09-05 | 2019-09-05 | B Purchase |
President and CEO Executive Director |
20,000
+6.2%
2.10USD 42,000 |
20,000 +6.2% | 2.10 | USD 42,000 | |
| 2018-10-11 | 2018-10-09 | B Purchase |
Pisano Wayne Non-Executive Director |
2,000
+inf%
4.59USD 9,180 |
2,000 +inf% | 4.59 | USD 9,180 | |
| 2018-05-29 | 2018-05-25 | B Purchase |
Enright William President and CEO Executive Director |
1,300
+0.4%
0.51USD 660 |
1,300 +0.4% | 0.51 | USD 660 | |
| 2018-01-03 | 2017-12-29 | B Purchase |
SAYARE MITCHEL Non-Executive Director |
5,100
+18.5%
1.95USD 9,963 |
5,100 +18.5% | 1.95 | USD 9,963 | |
| 2018-01-02 | 2017-12-29 | B Purchase |
SCHAFFER DERACE L Non-Executive Director |
38,699
+7.0%
1.93USD 74,778 |
38,699 +7.0% | 1.93 | USD 74,778 | |
| 2018-01-02 | 2017-12-28 | B Purchase |
SCHAFFER DERACE L Non-Executive Director |
58,711
+11.9%
1.92USD 112,672 |
58,711 +11.9% | 1.92 | USD 112,672 | |
| 2017-12-27 | 2017-12-27 | B Purchase |
SCHAFFER DERACE L |
27,706
+6.0%
1.77USD 49,040 |
27,706 +6.0% | 1.77 | USD 49,040 | |
| 2017-12-27 | 2017-12-27 | B Purchase |
SCHAFFER DERACE L |
50,000
+12.1%
1.76USD 88,170 |
50,000 +12.1% | 1.76 | USD 88,170 | |
| 2017-12-27 | 2017-12-26 | B Purchase |
SCHAFFER DERACE L |
51,442
+14.2%
1.81USD 93,269 |
51,442 +14.2% | 1.81 | USD 93,269 | |
| 2017-12-27 | 2017-12-22 | B Purchase |
SCHAFFER DERACE L |
17,982
+5.2%
1.61USD 28,877 |
17,982 +5.2% | 1.61 | USD 28,877 | |
| 2017-12-08 | 2017-12-07 | B Purchase |
SCHAFFER DERACE L |
7,639
+2.3%
1.74USD 13,308 |
7,639 +2.3% | 1.74 | USD 13,308 | |
| 2017-12-08 | 2017-12-06 | B Purchase |
SCHAFFER DERACE L |
16,106
+5.0%
1.80USD 28,996 |
16,106 +5.0% | 1.80 | USD 28,996 | |
| 2017-12-05 | 2017-12-05 | B Purchase |
SCHAFFER DERACE L |
13,495
+4.4%
1.78USD 23,987 |
13,495 +4.4% | 1.78 | USD 23,987 | |
| 2017-12-05 | 2017-12-04 | B Purchase |
SCHAFFER DERACE L |
7,300
+2.4%
1.81USD 13,195 |
7,300 +2.4% | 1.81 | USD 13,195 | |
| 2017-12-05 | 2017-12-01 | B Purchase |
SCHAFFER DERACE L |
5,215
+1.8%
1.80USD 9,405 |
5,215 +1.8% | 1.80 | USD 9,405 | |
| 2017-11-30 | 2017-11-30 | B Purchase |
SCHAFFER DERACE L |
12,978
+4.6%
1.84USD 23,816 |
12,978 +4.6% | 1.84 | USD 23,816 | |
| 2017-11-30 | 2017-11-29 | B Purchase |
SCHAFFER DERACE L |
7,942
+2.9%
1.94USD 15,377 |
7,942 +2.9% | 1.94 | USD 15,377 | |
| 2017-11-30 | 2017-11-28 | B Purchase |
SCHAFFER DERACE L |
12,395
+4.7%
1.97USD 24,445 |
12,395 +4.7% | 1.97 | USD 24,445 | |
| 2017-11-27 | 2017-11-27 | B Purchase |
SCHAFFER DERACE L |
10,042
+4.0%
2.00USD 20,060 |
10,042 +4.0% | 2.00 | USD 20,060 | |
| 2017-11-27 | 2017-11-24 | B Purchase |
SCHAFFER DERACE L |
6,505
+2.7%
2.02USD 13,162 |
6,505 +2.7% | 2.02 | USD 13,162 | |
| 2017-11-27 | 2017-11-22 | B Purchase |
SCHAFFER DERACE L |
5,261
+2.2%
2.10USD 11,061 |
5,261 +2.2% | 2.10 | USD 11,061 | |
| 2017-11-21 | 2017-11-21 | B Purchase |
SCHAFFER DERACE L |
7,236
+3.1%
2.06USD 14,905 |
7,236 +3.1% | 2.06 | USD 14,905 | |
| 2017-11-21 | 2017-11-20 | B Purchase |
SCHAFFER DERACE L |
4,800
+2.1%
2.07USD 9,958 |
4,800 +2.1% | 2.07 | USD 9,958 | |
| 2017-11-21 | 2017-11-17 | B Purchase |
SCHAFFER DERACE L |
6,295
+2.8%
2.12USD 13,352 |
6,295 +2.8% | 2.12 | USD 13,352 | |
| 2017-08-28 | 2017-08-25 | B Purchase |
SCHAFFER DERACE L |
50,000
+29.1%
2.25USD 112,390 |
50,000 +29.1% | 2.25 | USD 112,390 | |
| 2017-08-28 | 2017-08-24 | B Purchase |
SCHAFFER DERACE L |
17,326
+11.2%
2.24USD 38,892 |
17,326 +11.2% | 2.24 | USD 38,892 | |
| 2017-08-24 | 2017-08-23 | B Purchase |
Drutz David |
5,000
+19.4%
2.27USD 11,340 |
5,000 +19.4% | 2.27 | USD 11,340 | |
| 2017-08-23 | 2017-08-23 | B Purchase |
SCHAFFER DERACE L |
43,352
+39.0%
2.22USD 96,350 |
43,352 +39.0% | 2.22 | USD 96,350 | |
| 2017-08-24 | 2017-08-22 | B Purchase |
Drutz David |
5,000
+24.1%
2.15USD 10,758 |
5,000 +24.1% | 2.15 | USD 10,758 | |
| 2017-08-23 | 2017-08-22 | B Purchase |
SCHAFFER DERACE L |
5,958
+5.7%
2.10USD 12,519 |
5,958 +5.7% | 2.10 | USD 12,519 | |
| 2017-08-23 | 2017-08-21 | B Purchase |
SCHAFFER DERACE L |
690
+0.7%
2.02USD 1,395 |
690 +0.7% | 2.02 | USD 1,395 | |
| 2018-02-23 | 2017-06-06 | B Purchase |
Roberts M Scot Chief Scientific Officer Officer |
449
+inf%
4.42USD 1,985 |
449 +inf% | 4.42 | USD 1,985 | |
| 2017-06-06 | 2017-06-02 | B Purchase |
GILL JOHN |
1,000
+1.2%
4.34USD 4,344 |
1,000 +1.2% | 4.34 | USD 4,344 | |
| 2016-12-09 | 2016-12-09 | S Sale |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. Large shareholder |
436,324
-6.2%
3.26USD 1,422,416 |
436,324 -6.2% | 3.26 | USD 1,422,416 | |
| 2016-12-09 | 2016-12-08 | S Sale |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. Large shareholder |
440,479
-5.9%
3.25USD 1,431,557 |
440,479 -5.9% | 3.25 | USD 1,431,557 | |
| 2016-12-09 | 2016-12-07 | S Sale |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. Large shareholder |
477,829
-6.0%
3.26USD 1,557,723 |
477,829 -6.0% | 3.26 | USD 1,557,723 | |
| 2016-04-15 | 2016-04-13 | PS Planned sale |
RICHMAN ERIC I Non-Executive Director |
75,000
-29.8%
2.20USD 165,000 |
75,000 -29.8% | 2.20 | USD 165,000 | |
| 2016-04-15 | 2016-04-13 | PS Planned sale |
RICHMAN ERIC I Non-Executive Director |
91,121
-34.0%
2.20USD 200,466 |
91,121 -34.0% | 2.20 | USD 200,466 | |
| 2016-04-15 | 2016-04-13 | PS Planned sale |
RICHMAN ERIC I Non-Executive Director |
150,000
-45.9%
2.20USD 330,000 |
150,000 -45.9% | 2.20 | USD 330,000 |